Cargando…

Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine

Autoimmune bullous diseases (AIBDs) are a heterogeneous group of life-threatening disorders associated with subepidermal or intraepidermal blistering. Skin barrier alterations and prolonged immunosuppressive treatments increase the risk of infections in patients with AIBDs, who are considered fragil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pira, Anna, Sinagra, Jo Linda Maria, Moro, Francesco, Mariotti, Feliciana, Di Zenzo, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893122/ https://www.ncbi.nlm.nih.gov/pubmed/36744126 http://dx.doi.org/10.3389/fmed.2023.1112823

Ejemplares similares

Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis
por: Moro, Francesco, et al.
Publicado: (2022)

Bullous Pemphigoid: Trigger and Predisposing Factors
por: Moro, Francesco, et al.
Publicado: (2020)

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Pira, Anna, et al.
Publicado: (2023)

156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset
por: Pira, A., et al.
Publicado: (2023)

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Case report: A rare case of imiquimod-induced atypical pemphigus vulgaris
por: Moro, Francesco, et al.
Publicado: (2022)

Humoral Epitope Spreading in Autoimmune Bullous Diseases
por: Didona, Dario, et al.
Publicado: (2018)

Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab
por: Sinagra, Jo Linda, et al.
Publicado: (2021)

Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening
por: Di Zenzo, Giovanni, et al.
Publicado: (2022)

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience
por: Merli, Martina, et al.
Publicado: (2023)

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets
por: Maglie, Roberto, et al.
Publicado: (2023)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights
por: D’Astolto, Roberto, et al.
Publicado: (2023)

Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
por: Kianfar, Nika, et al.
Publicado: (2022)

Prurigo pigmentosa clinically and immunologically mimicking autoimmune bullous disease: A case report
por: Kita, Kanako, et al.
Publicado: (2022)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Rituximab for linear immunoglobulin A bullous dermatosis
por: Dhillon, Rummit, et al.
Publicado: (2022)

May bullous pemphigoid be worsened by COVID-19 vaccine?
por: Cozzani, Emanuele, et al.
Publicado: (2022)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
por: Di Lullo, Giulia, et al.
Publicado: (2019)

The Autoimmune Bullous Diseases
por: Wakelin, S H, et al.
Publicado: (1997)

Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin
por: Chouchane, Karim, et al.
Publicado: (2021)

Linear IgA bullous dermatosis treated with rituximab
por: Pinard, Camille, et al.
Publicado: (2019)

Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic
por: Corrà, Alberto, et al.
Publicado: (2021)

Therapy of autoimmune bullous diseases
por: Mutasim, Diya F
Publicado: (2007)

Autoimmune Bullous Disease in Childhood
por: Salman, Andac, et al.
Publicado: (2017)

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset
por: Russo, Roberto, et al.
Publicado: (2022)

Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder
por: Aashish, et al.
Publicado: (2022)

Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Kasperkiewicz, Michael, et al.
Publicado: (2022)

Interaction of Psoriasis and Bullous Diseases
por: Dainichi, Teruki, et al.
Publicado: (2018)

Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
por: Mitra, Debdeep, et al.
Publicado: (2022)

IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients
por: Lamberts, A., et al.
Publicado: (2020)

Bullous cutaneous reactions
por: Jira, Mohamed, et al.
Publicado: (2018)

Fascial Nomenclature: Update 2022
por: Bordoni, Bruno, et al.
Publicado: (2022)

Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires
por: Saleh, Marwah Adly, et al.
Publicado: (2019)

The Impact of the Initial Phase of the COVID-19 Pandemic on Patients With Autoimmune Bullous Diseases
por: Örnek, Sinem, et al.
Publicado: (2023)

Bullous Pemphigoid Complicated by Sepsis
por: Shah, Dipal, et al.
Publicado: (2022)

The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study
por: Kridin, Khalaf, et al.
Publicado: (2020)

Exacerbation of bullous pemphigoid after hand, foot, and mouth disease treated with rituximab
por: Batts, Alfreda F., et al.
Publicado: (2016)

Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
por: Kunadia, Anuj, et al.
Publicado: (2021)

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
por: Cao, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_377spfvnmfm562l5v9umb7hg0b